• AcuCort CEO Jonas Jönmark held a live interview on Oct. 6 focused on the company’s rights issue financing.
• Discussion covered use of proceeds, preparations for a planned US NDA for Zeqmelit, US launch planning.
• Management also addressed the FDA process, international expansion strategy, and near-term corporate milestones.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AcuCort AB published the original content used to generate this news brief via Cision (Ref. ID: 202610060300BITN____UKPR__EN_20261005-BIT-9317-0) on October 06, 2026, and is solely responsible for the information contained therein.